The genomic profiling of the GB samples included in our study confirmed the presence of common glioblastoma alterations reported in previous studies [4]: loss/partial loss of chromosome 10, polysomy of chromosome 7, focal deletion of the CDKN2A/B and focal high-level amplifications of EGFR. This evidence concerns the gene CDKN2A and glioblastoma.